Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Testing efficacy or toxicity of a compound or composition
Patent
1995-06-06
1999-01-12
Chambers, Jasemine C.
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Testing efficacy or toxicity of a compound or composition
424 7831, 424 7835, 435 78, 435 795, 435 793, 435 792, 530350, 5147724, 800 2, A61K 3174, A61K 31785, A61K 31795, A61K 4732
Patent
active
058583262
ABSTRACT:
In vivo and in vitro methods of increasing amyloid deposition using amyloid-enhancing compounds are described. Methods of forming amyloid fibrils and screening for agents useful in treating amyloidosis are also described. Animals having non-naturally occurring amyloid deposits produced using the amyloid-enhancing compounds even further are described.
REFERENCES:
patent: 4816416 (1989-03-01), Averback
patent: 4919915 (1990-04-01), Averback
patent: 5164295 (1992-11-01), Kisilevsky
patent: 5216127 (1993-06-01), Hirai et al.
patent: 5221607 (1993-06-01), Cordell et al.
patent: 5262303 (1993-11-01), Sipe et al.
Kisilevsky et al., Critical Reviews in Clinical Laboratory Sciences, vol. 29:1, pp. 59-82, 1992.
Snow et al., Neuron, vol. 12: 1, pp. 219-234, 1994.
Glombitza, K.W., et al., "Phenolsulphate esters from Phaeophyceae", Bull. Liaison-Groupe Polyphenols. vol. 14, pp. 244-247 (1988).
Ragan, M., "Phenol sulfate esters: ultraviolet, infrared, .sup.1 H and .sup.13 C nuclear magnetic resonance spectroscopic investigation", Can. J. Chem. vol. 56, No. 20, pp. 2681-2685 (1978).
Ragan, M., et al. "Paired-Ion Reversed-Phase High-Performance Liquid Chromotography of Phenol Sulfater in Synthetic Mixtures, Algal Extracts and Urine", Journal of Chromatography, vol. 178, pp. 505-513 (1979).
International Search Report dated Oct. 18, 1996.
Kirschner, D.A., et al., "Synthetic peptide homologous to .beta. protein from Alzheimer disease forms amyloid-like fibrils in vitro", Proc. Natl. Acad. Sci USA 84: 6953-6957 1987.
Castano, E.M., et al, "In Vitro Formation of Amyloid Fibrils from Two Synthetic Peptides of Different Lengths Homologous to Alzheimer's Disease .beta.-Protein", Biochemical and Biophysical Research Communications 141:782-789 (1986).
Gruys, E., et al, "Animal models for reactive amyloidosis", Bailliere's Clinical Rheumatology 8: 599-611 (1994).
Gorevic, P.D., et al., "Ten to Fourteen Residue Peptides of Alzheimer's Disease Protein are Sufficient for Amyloid Fibril Formation and its Characteristic Xray Diffraction Pattern", Biochemical and Biophysical Research Communications 147:854-862 (1987).
WHO-IUIS Nomenclature Sub-Committee, "Nomenclature of amyloidosis", Bulletin of the World Health Organization 71:105-108 (1993).
Connors, L.H., et al., "In Vitro Formation of Amyloid Fibrils from Intact .sigma..sub.2 Microglobulin", Biochemical and Biophysical Research Communications 3: 1063-1068 (1985).
Magnus, J.H., et al., "Proteoglycans, glycosaminoglycans and amyloid deposition", Bailliere's Clinical Rheumatology 8: 575-597 (1994).
Nitta A., et al, ".beta.-Amyloid protein-induced Alzheimer's disease animal model", Neuroscience letters 170: 63-66 (1994).
Li, X.A., et al., "Binding of serum amyloid P component heparin in human serum", Biochimica et Biophysica Acta 1201: 143-148 (1994).
Schwarzman, A.L., et al. "Transthyretin sequesters amyloid .beta.-protein and prevents amyloid formation", Proc. Natl. Acad. Sci. USA 91: 8638-8372 (1994).
Merlini, G., "Treatment of Primary Amyloidosis" Seminars in Hematology 32: 60-79 (1995).
Glenner, G.G., et al., "Creation of `Amyloid` Fibrils from Bence Jones Proteins in vitro", National Institutes of Health 174: (Nov. 1971).
Caughey, B., et al., "Scrapie-associated PrP Accumulation and Its Inhibition: Revisiting the Amyloid-Glycosaminoglycan Connection", Annals New York Academy of Sciences 290-295.
Fraser Paul
Kisilevsky Robert
Kong Xianqi
Szarek Walter
Weaver Donald
Chambers Jasemine C.
DeConti, Jr. Giulio A.
Hanley Elizabeth A.
Neurochem, Inc.
Queen's University at Kingston
LandOfFree
Methods of increasing amyloid deposition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of increasing amyloid deposition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of increasing amyloid deposition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1511637